National trend of antidepressant consumption and its impact on suicide rate in Hungary

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 4, 2008, Pages 401-405

  Viola, Réka ^a   Benko, Ria ^a   Nagy, Gábor ^b   Soós, Gyöngyvér ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b IMS PharmMIS Consulting Company   (Hungary)

Author keywords

Antidepressant consumption; Suicide rate; Trend analysis

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DIBENZEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ARTICLE; CORRELATION COEFFICIENT; DRUG MARKETING; DRUG UTILIZATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUNGARY; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUICIDE; TREND STUDY; FEMALE; MALE; STATISTICAL MODEL; STATISTICS;

ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; HUNGARY; LINEAR MODELS; MALE; RETROSPECTIVE STUDIES; SUICIDE;

EID: 42149123341     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1574     Document Type: Article

References (16)

1. Szadóczky E, Papp Z, Vitrai J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord 1998; 50(2-3): 153-162.
2. De Leo D, Evans R. International Suicide Rates and Prevention Strategies. Hogrefe and Huber Publishers: Göttingen, Germany, 2004; ISBN: 0889372888.
3. Kelly CB, Ansari T, Rafferty T, Stevenson M. Antidepressant prescribing and suicide rate in Northem Ireland. Eur Psychiatry 2003; 18(7): 325-328.
4. Hall WD, Mant A, Mitchel PB, Rendle VA, Hickie IB, McManus P. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. Br Med J 2003; 326(739): 1008-1012.
5. Barbui C, Campomori A, D'Avanzo B, Negri E, Garattini S. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 1999; 34(3): 152-156.
6. Helgason T, Tomasson H, Zoega T. Antidepressants and public health in Iceland. Time series analysis of national data. Br J Psychiatry 2004; 184: 157-162.
7. Reseland S, Bray I, Gunnell D. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br J Psychiatry 2006, 189: 354-358.
8. Olie JP, Elomari F, Spadone C, Lepine JP. Antidepressants consumption in the global population in France. Encephale 2002; 28(5Ptl): 411-417.
9. Furst J, Kocmur M. Use of psychiatric drugs in Slovenia in comparison to Scandinavian countries. Pharmacoepidemiol Drug Saf 2003; 12(5): 399-403.
10. Schwabe U, Paffrath D. Arzneiverordnungsreport: Psychopharmaka-Verordnungen. Springer-Verlag: Berlin, 2004; ISBN: 3540213597.
11. Kopp M, Szedmák S, Löke J, Skrabski A. A depressziós tüneteggyüttes gyakorisága és egészségügyi jelentosége a magyar lakosság körében. Lege Artis Medicinae 1997; 7(3): 136-144.
12. Johan Béla National Center for Epidemiology. National Health Interview Survey Hungary, 2003; http://www.oek.hu/oek.web
13. Meijer WE, Heerdink ER, Leufkens HG, Herings RMC, Egberts ACG, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004; 60(1): 57-61.
14. Balázs J, Lecrubier Y, Csiszér N, Koszták, Bitter I. Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. J Affect Disord 2003; 76(1-3): 113-119.
15. Szadóczky E, Vitrai J, Rihmer Z, Füredi J. Suicide attempts in the Hungarian adult population. Their relation with DIS/DSM-III-R affective and anxiety disorders. Eur Psychiatry 2000; 15(6): 343-347.
16. Isacsson G. Suicide prevention - a medical breakthrough? Acta Psychiatr Scand 2000; 102(2): 113-117.